TP53 and prostate carcinoma: In a later report, the authors demonstrated that sGCα1 expression is positively regulated by 280B, a transcription factor overexpressed in prostate cancer that also promotes p53 degradation by upregulation of mdm2, which promotes p53 ubiquitination [144].